Biography

Megan Null, MPH, is an experienced epidemiologist with 17 years of expertise in tuberculosis (TB) immunology research. She has worked extensively on clinical and laboratory-based TB research, including clinical trials conducted in the United States, Tanzania, and Uganda. Recently, she served as a trial coordinator for a randomized trial of anti-TB therapy for adults with HIV and TB-related sepsis in Tanzania and Uganda. Megan is passionate about global health research and international collaboration. She is well-versed in managing and training technicians both domestically and internationally.

Expertise

TB Diagnostics
Public Health

Key Impacts

Tuberculosis-related sepsis is associated with increased in-hospital mortality across Universal Vital Assessment mortality risk score groups in adults in Mbarara, Uganda

Adults with TB-related sepsis were at higher risk of death compared to those without TB even after stratifying for severity of illness. A high index of clinical suspicion for TB, improved TB diagnostics, and more efficacious anti-TB therapies are urgently needed for patients with sepsis in Africa.

Source: Conference 2024

Research Summaries

PAPER
Immune patterns predict tuberculosis and death in sepsis with high HIV in East Africa
02 Dec 2025